Sclerosis multiplex (SM): vizsgálatok itt: Argentína

3 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

• 2. fázisTaking people
  A Pharmacokinetics (PK), Pharmacodynamics (PD), Safety and Tolerability Study of Fenebrutinib in Children and Adolescents With Relapsing Multiple Sclerosis (RMS)

  Where

  Rosario, San Miguel de Tucumán

  Életkor

  10 év to 17 év

  People

  12 worldwide

  Run by

  Hoffmann-La Roche

  See details and how to joinNCT07161258 · EU 2024-519800-28-00
• 3. fázisTaking people
  Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

  Where

  Buenos Aires, CABA, Rosario

  Életkor

  40 év to 70 év

  People

  400 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT06846281 · EU 2023-509275-17-00
• 3. fázisTaking people
  A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

  Where

  Bombal, Buenos Aires, CABA, Capital Federal, Rosario, San Juan, San Miguel de, Santiago del Estero

  Életkor

  18 év to 65 év

  People

  1275 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT07225504